Age-related macular degeneration (AMD) is the leading cause of blindness in Western countries, affecting the retinal region known as the macula and responsible for central vision. AMD is typically classified

Macular degeneration, also known as macular atrophy (AMD), is a common eye condition characterized by retinal breakdown and central vision loss. Macular degeneration may present in two forms: dry or

Macular degeneration affects the macula of your retina and, while not causing total blindness, makes it harder for people to view fine details or straight lines clearly and read books

Anti-vascular endothelial growth factor (anti-VEGF), is the best treatment for wet AMD. Regular injections with this drug prevent new abnormal blood vessels from growing beneath the retina and leaking. This

Sub-Intravitreous injection of drugs has been found to slow the formation of leaky blood vessels typical of exudative wet age-related macular degeneration (AMD), providing another strategy to protect against further

Age Related Macular Degeneration (AMD) results in the degeneration of the central portion of your retina that controls your straight ahead vision, leading to gradual loss of central vision while